Funding Opportunities
Open for application
CALL 2025-1 / EXPLORATION
This call is dedicated to basic research to uncover the underlying mechanisms that drive the onset, growth, and spread of cancer. Its aim is to address knowledge gaps, gain new scientific insights, and identify new leads and targets for preventive, diagnostic and therapeutic purposes. The call is intended for project proposals within the Basic research and Credentialing phases.
Call number: | 2025-1 / EXPL |
Opening: | 24 September 2024 |
Closure: | 19 November 2024 |
Consortium/YIG-interviews: | Mid-April 2025 |
Funding decision: | July 2025 |
CALL 2025-2 / DEVELOPMENT
Development is outlined as the process needed to translate research findings into practical implementation. The Development Call is reserved for project proposals within the Creation of Modality, Preclinical, Clinical and Implementation research phase.
Call number: | 2025-2 / DEV |
Opening: | 24 September 2024 |
Closing: | 26 November 2024 |
Consortium/YIG-interviews: | May 2025 |
Funding decision: | July 2025 |
PPP PILOT 2024
KWF has been given the opportunity to participate in the Health~Holland PPS Pilot of 2024. The purpose of this pilot is to allow parties to gain experience with the structure of the new 'PPP Innovation Subsidy Regulation'. This includes, among other things, new funding conditions.
Call opens: | 28 June 2024 |
Call closes: | 1 October 2024 (12.00 noon) |
Funding decision: | Mid-February 2025 |
LONG-TERM PROGRAMME BIOMARKERS
This programme is intended to bring validated biomarkers into practice.
Call number: | 2025-LTP |
Call type: | Long-term programme |
Contact address: | [email protected] |
|
|
Opening checklist: | 3 September 2024 |
Opening pre-proposals: | 24 September 2024 |
Closure checklist: | 22 October 2024 |
Closure pre-proposals: | 3 December 2024 (12.00 noon) |
Opening full proposals: | 28 January 2025 |
Closure full proposals: | 1 April 2025 (12.00 noon) |
Interviews: | 27 May 2025 |
Funding decision: | July 2025 |
ATTRACT 2025: INTERNATIONAL CALL FOR RESEARCH PROPOSALS ON RARE CANCER DRUG DEVELOPMENT
6 European anti-cancer charities join forces and launch the ATTRACT 2025 call to stimulate international research on the treatment of rare cancers. We are pioneering with this partnership to tackle the funding gap for international research projects, especially in the field of rare cancer therapeutics. Our ambitious aim is to improve the treatment of rare cancers by helping new drug innovations from research into clinical practice, making the best possible treatments accessible to rare cancer patients everywhere.
- Provisional Timeline
Application Open Pre-proposal: | 9 September, 2024 |
Application Deadline Pre-proposal: | 11 October 2024, 3pm CET |
Application Open Full proposal: | First half of Feb 2025 |
Application Deadline Full proposal: | End of April 2025 |
Rebuttal week: | First half of Sep 2025 |
Funding decisions: | Oct-Nov 2025 |
Upcoming calls (subject to changes)
PROOF OF CONCEPT 2025-1
With the Proof of Concept (PoC) programme KWF wants to stimulate the translation of impactful innovations to ensure they reach patients more quickly. The programme focuses on mapping out the path towards (clinical) application. The PoC application must be related to an ongoing or recently finished KWF project (up to 6 months after completion).
Call number: | 2025-1 PoC |
Call type: | open call |
Contact address: | [email protected] |
- Timeline
Call opens: | 2 December 2024 |
Call closes: | 21 January 2025 (12.00 noon) |
Funding decision: | 8 April 2025 |
PROOF OF CONCEPT 2025-2
With the Proof of Concept (PoC) programme KWF wants to stimulate the translation of impactful innovations to ensure they reach patients more quickly. The programme focuses on mapping out the path towards (clinical) application. The PoC application must be related to an ongoing or recently finished KWF project (up to 6 months after completion).
Call number: | 2025-2 PoC |
Call type: | open call |
Contact address: | [email protected] |
- Timeline
Call opens: | Mid-April 2025 |
Call closes: | 27 May 2025 (12.00 noon) |
Funding decision: | Mid-September 2025 |
PROOF OF CONCEPT 2025-3
With the Proof of Concept (PoC) programme KWF wants to stimulate the translation of impactful innovations to ensure they reach patients more quickly. The programme focuses on mapping out the path towards (clinical) application. The PoC application must be related to an ongoing or recently finished KWF project (up to 6 months after completion).
Call number: | 2025-3 PoC |
Call type: | open call |
Contact address: | [email protected] |
- Timeline
Call opens: | End of June 2025 |
Call closes: | 23 September 2025 (12.00 noon) |
Funding decision: | December 2025 |
Closed calls (awaiting funding decision)
CALL PHARMACEUTICAL PRODUCT DEVELOPMENT FROM INNOVATIVE ACADEMIC RESEARCH (PIPELINE)
The PIPELINE call aims at the clinical development of new pharmaceuticals that originate from academic research and have the potential to substantially improve the treatment for cancer patients with unmet medical needs. Any type of pharmaceutical that is regulated as a medical product in the European Union is eligible.
Opening pre-applications: | 19 September 2023 |
Closure pre-applications: | 30 November 2023 |
Opening pre-proposals: | 9 January 2024 |
Closure pre-proposals: | 19 March 2024 (12.00 Noon) |
Opening full proposals: | 4 June 2024 |
Closure full-proposals: | 10 September 2024 (12.00 Noon) |
Funding decision: | 12 December 2024 |
THEME CALL SMART MEASUREMENT TECHNOLOGY
The aim of this call is to stimulate the further development of smart measurement technology to provide (early) diagnosis and monitoring of oncological patients in a minimally invasive manner and closer to home.
Opening pre-proposals: | 5 March 2024 |
Closure pre-proposals: | 7 May 2024 (12.00 noon) |
Closure full proposals: | 10 September 2024 (12.00 noon) |
Consortium interviews: | 12 November 2024 |
Funding decision: | December 2024 / January 2025 |
THEME CALL ADVANCEMENT OF BIOMARKERS TO DAILY PRACTICE
The aim of this call is to validate (combinations of) already discovered, promising biomarkers that correlate with patient relevant outcomes or treatment responses and that can be used in daily clinical practice in the near future. Therefore, efforts are needed to set up collaborative, multidisciplinary studies with special attention to (combinations of) biomarkers that are potential candidates for clinical implementation. The focus of this call is to bring together the necessary expertise in the field of biomarker research and clinical care to reach the next developmental phase of the biomarker candidate(s) on their way to daily practice and to provide the appropriate framework and funding.
Opening: | 5 March 2024 |
Closure pre-proposals: | 7 May 2024 (12.00u) |
Closure full proposals: | 10 September 2024 (12.00 noon) |
Interviews: | Mid-November 2024 |
Funding decision: | December 2024 |
CALL 2024-3 / EXPLORATION
This call is dedicated to basic research to uncover the underlying mechanisms that drive the onset, growth, and spread of cancer. Its aim is to address knowledge gaps, gain new scientific insights, and identify new leads and targets for preventive, diagnostic and therapeutic purposes. The call is intended for project proposals within the Basic research and Credentialing phases.
Opening: | 20 February 2024 (12.00 noon) |
Closure: | 14 May 2024 (12.00 noon) |
Funding decision: | December 2024 |
Completed calls
THEME CALL PALLIATIVE CARE
The aim of this call is to contribute to an inclusive palliative care environment, where every patient, regardless of their cultural, religious or social background, receives respectful and high-quality care.
Opening pre-proposals | 3 October 2023 (12.00 noon) |
Closure pre-proposals: | 5 December 2023 (12.00 noon) |
Closure full proposals: | 28 May 2024 (12.00 noon) |
Funding decision: | 5 November 2024 |
Awarded grants: | Press release | List of awarded grants |
IMPLEMENTATION RESEARCH FOR CANCER PREVENTION IN EUROPE
Opening: | 15 December 2023 |
Closure: | 15 March 2024 |
Funding decision: | 11 September 2024 |
Awarded grants: | Press release KWF / Press release UICC |
CALL 2024-2 / DEVELOPMENT
Opening: | 22 August 2023 (12.00 noon) |
Closure: | 7 November 2023 (12.00 noon) |
Consortium/YIG-interviews | 23 & 25 April 2024 |
Funding decision: | 16 July 2024 |
Awarded grants: | List of awarded grants |
LONG-TERM PROGRAMME BIOMARKERS
This program is intended to successfully bring promising biomarker(s) that have already demonstrated good validation into practice.
Opening checklist: | 14 September 2023 |
Closure checklist: | 6 November 2023 (12.00 noon) |
Opening pre-proposals: | 3 October 2023 |
Closure pre-proposals: | 5 December 2023 (12.00 noon) |
Opening full proposals: | 30 Januari 2024 |
Closure full proposals: | 9 April 2024 (12.00 noon) |
Funding decision: | 9 July 2024 [ |
Awarded grant: | See press release [Dutch] |